FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Austral IPO and Chemcel Biotech IPO.
Austral IPO is a Mainline Fixed Price Issue IPO proposed to list at BSE, NSE while Chemcel Biotech IPO is a Mainline Fixed Price Issue proposed to list at BSE.
Austral IPO | Chemcel Biotech IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Fixed Price Issue |
Listing At | BSE, NSE | BSE |
Lead Managers | Allahabad Bank Saffron Capital Advisors Private Limited |
Allahabad Bank |
Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Austral IPO is up to ₹142.30 Cr whereas the issue size of the Chemcel Biotech IPO is up to ₹24.64 Cr. The final issue price of Austral IPO is ₹196.00 per share and of Chemcel Biotech IPO is ₹16.00 per share.
Austral IPO | Chemcel Biotech IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹164.00 per share | |
Issue Price (Upper) | ₹196.00 per share | |
Issue Price (Final) | ₹196.00 per share | ₹16.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 34 shares | |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 72,60,000 shares | 1,54,00,000 shares |
Issue Size Total (Amount) | up to ₹142.30 Cr | up to ₹24.64 Cr |
Austral IPO opens on Aug 07, 2008, while Chemcel Biotech IPO opens on Sep 09, 2008. The closing date of Austral IPO and Chemcel Biotech IPO is Aug 13, 2008, and Sep 12, 2008, respectively.
Austral IPO | Chemcel Biotech IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Aug 07, 2008 | Sep 09, 2008 |
Issue Close | Aug 13, 2008 | Sep 12, 2008 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Austral IPO P/E ratio is , as compared to Chemcel Biotech IPO P/E ratio of .
Austral IPO | Chemcel Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 87.41% | 57.23% | ||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 65.56% | 29.4% | ||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 10.85%% | 9.14%% |
In the Austral IPO retail investors (RII) are offered while in Chemcel Biotech IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Austral IPO and in Chemcel Biotech IPO.
Austral IPO | Chemcel Biotech IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | ||
NII | ||
RII | ||
Employee | ||
Others | ||
Total |
Austral IPO subscribed 1.65x in total, whereas Chemcel Biotech IPO subscribed .
Austral IPO | Chemcel Biotech IPO | |
---|---|---|
QIB (times) | 0.62x | |
NII (times) | 7.32x | |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 0.69x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.65x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|